Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

TBXU vs. HIBS: which is better?

Bottom line

TBXU vs HIBS: the short answer

TBXU (Direxion Daily Biotech Top 5 Bull 2X ETF) and HIBS (Direxion Daily S&P 500(R) High Beta Bear 3X ETF) are both etfs.

TBXU is cheaper at 0.98% vs 1.06% — a difference of $8.00 a year per $10,000 invested.

Updated Nov 19, 2026

TBXU vs HIBS side by side

TBXUHIBS
TypeETFETF
Fund familyDirexionDirexion
CategoryLeveraged & InverseLeveraged & Inverse
Expense ratio0.98%1.06%
Annual cost per $10k$98$106
10-yr cost on $10k (prospectus)$5,645$1,347
Max front loadNoneNone
12b-1 fee0%0%
1-yr return—−72.4%
5-yr return (annualized)—−55.6%
10-yr return (annualized)——
Best quarter—+74.7%
Worst quarter—−79.0%
Net assets (fund)$2.6M$22.6M
Number of holdings108
Portfolio turnover69%%
Returns as of—Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

5 of TBXU's top 10 holdings also appear in HIBS's top 8.

Shared top holdings
HoldingTBXUHIBS
Goldman Financial29.36%28.96%
Dreyfus21.64%48.43%
Goldman Sachs Liq Es Fd A6.23%26.65%
N/a2.83%1.18%
N/a0.62%1.18%

Source: SEC Form N-PORT

TBXU top 10

  1. Goldman Financial — 29.36%
  2. Dreyfus — 21.64%
  3. Regeneron Pharmaceuticals Inc — 9.09%
  4. Amgen Inc — 7.95%
  5. Vertex Pharmaceuticals Inc — 7.84%
  6. Gilead Sciences Inc — 7.58%
  7. Argenx Se - Adr — 6.98%
  8. Goldman Sachs Liq Es Fd A — 6.23%
  9. N/a — 2.83%
  10. N/a — 0.62%

HIBS top 10

  1. Dreyfus — 48.43%
  2. Goldman Financial — 28.96%
  3. Goldman Sachs Liq Es Fd A — 26.65%
  4. N/a — 5.90%
  5. N/a — 2.40%
  6. N/a — 2.21%
  7. N/a — 1.19%
  8. N/a — 1.18%

FAQ

What is the difference between TBXU and HIBS?
TBXU (Direxion Daily Biotech Top 5 Bull 2X ETF) and HIBS (Direxion Daily S&P 500(R) High Beta Bear 3X ETF) are both etfs. TBXU is cheaper at 0.98% vs 1.06% — a difference of $8.00 a year per $10,000 invested.
Which is cheaper, TBXU or HIBS?
TBXU has the lower expense ratio (0.98%).
Should I own both TBXU and HIBS?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.